Immunology of Drug-Resistant Tuberculosis (DR-TB): A Literature Review
DOI:
https://doi.org/10.36497/jri.v45i4.958Abstract
One of the oldest infectious illnesses, tuberculosis (TB) continues to be a serious global health concern. With an estimated 1.060.000 cases, Indonesia is the second-largest provider of tuberculosis cases worldwide after India. According to the Ministry of Health in 2024, 12.531 cases were MDR-TB/RR-TB. This number has increased compared to 2021, which was 7.876 cases. Resistance may occur primarily or secondarily. Primary resistance is caused by infection with a drug-resistant strain, while secondary resistance occurs during the treatment process. Secondary resistance is divided into intrinsic and acquired. In intrinsic resistance, infection is caused by TB germs that have evolved, causing resistance through several mechanisms, namely reducing cell membrane permeability, drug reflux, degradation and target modification, while acquired resistance is caused by chromosomal mutations in target genes during the treatment process. The immunological mechanism that play a role in the occurrence of resistance will be discussed in this literature review.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Irene Oinike, dr. Dewi Wijaya, Sp.P(K)

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.











